SR-3677
CAS No. 1072959-67-1
SR-3677 ( —— )
产品货号. M23281 CAS No. 1072959-67-1
SR-3677 是一种有效且特异性的 ROCK2 抑制剂 (IC50: 3 nM)。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥282 | 有现货 |
|
| 5MG | ¥471 | 有现货 |
|
| 10MG | ¥787 | 有现货 |
|
| 25MG | ¥1469 | 有现货 |
|
| 50MG | ¥2465 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥519 | 有现货 |
|
生物学信息
-
产品名称SR-3677
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述SR-3677 是一种有效且特异性的 ROCK2 抑制剂 (IC50: 3 nM)。
-
产品描述SR-3677 is an effective and specific inhibitor of ROCK2 (IC50: 3 nM).(In Vitro):SR-3677 has an IC50 of ~3 nM in enzyme and cell based assays and has an off-target hit rate of 1.4% against 353 kinases, and inhibits only 3 out of 70 nonkinase enzymes and receptors. The IC50 value of SR-3677 for ROCK-I is 56±12 nM. The hydrophobic interaction of the benzodioxane phenyl ring with the hydrophobic surface of the pocket is the dominating factor that contributes to the high potency of SR-3677.(In Vivo): Pharmacology studies shows that SR-3677 is efficacious in both, increasing ex vivo aqueous humor outflow in porcine eyes and inhibiting myosin light chain phosphorylation. Continuous exposure of 25 μM SR-3677 increases the outflow facility by 60% at 1 h perfusion, increasing to 70–80% for the 2–5 h time points.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Autophagy
-
靶点Autophagy
-
受体Autophagy|ROCK1|ROCK2
-
研究领域——
-
适应症——
化学信息
-
CAS Number1072959-67-1
-
分子量408.45
-
分子式C22H24N4O4
-
纯度>98% (HPLC)
-
溶解度DMSO:40 mg/mL (97.93 mM)
-
SMILESCN(C)CCOC1=C(NC(C2OC(C=CC=C3)=C3OC2)=O)C=CC(C4=CNN=C4)=C1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Feng Y, et al. Discovery of substituted 4-(pyrazol-4-yl)-phenylbenzodioxane-2-carboxamides as potent and highly selective Rho kinase (ROCK-II) inhibitors. J Med Chem. 2008 Nov 13;51(21):6642-5.
产品手册
关联产品
-
XRK3F2
XRK3F2 是泛素结合蛋白 p62 (Sequestosome 1) 的特定 ZZ 结构域抑制剂,可抑制 MM 细胞生长并增强人 MM 细胞的 BMSC 生长。
-
Indole-3-Glyoxylyl C...
它是一种有机化合物,分子式为C10H6ClNO2。
-
CUR5g
CUR5g 是一种有效的自噬 (autophagy) 抑制剂。CUR5g 通过阻断自噬体-溶酶体融合选择性地抑制癌细胞中的自噬体降解。CUR5g 通过依赖 UVRAG 的机制阻止 STX17 募集到自噬体,导致自噬体无法与溶酶体融合。CUR5g 可提高顺铂 (Cisplatin,HY-17394) 在体外和体内对 A549 细胞的抗癌作用。
021-51111890
购物车()
sales@molnova.cn

